Publication | Closed Access

Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trial

OncologyClinical TrialsColorectal CancerMetastatic Colorectal CancerGercor DreamMaintenance TherapyPharmacotherapyCancer TreatmentMedicineRadiation OncologyHealth Sciences